These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 12297362

  • 21. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
    Powell M, McVey D, Kassim MH, Chen HY, Williams JD.
    J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
    [Abstract] [Full Text] [Related]

  • 22. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR, Huang WK, Shyr JM, Lau YJ, Liu YC, Luh KT.
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [Abstract] [Full Text] [Related]

  • 23. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children with acute otitis media in Japan from 2014 to 2017.
    Nagai K, Kimura O, Domon H, Maekawa T, Yonezawa D, Terao Y.
    J Infect Chemother; 2019 Mar; 25(3):229-232. PubMed ID: 30279114
    [Abstract] [Full Text] [Related]

  • 24. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
    Varon E, Levy C, De La Rocque F, Boucherat M, Deforche D, Podglajen I, Navel M, Cohen R.
    Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
    [Abstract] [Full Text] [Related]

  • 25. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2983-7. PubMed ID: 20137709
    [Abstract] [Full Text] [Related]

  • 26. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M, Browne FA, Jacobs MR, Appelbaum PC.
    Clin Ther; 2003 Jan 17; 25(1):169-77. PubMed ID: 12637118
    [Abstract] [Full Text] [Related]

  • 27. In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
    Jones RN, Biedenbach DJ, Croco MA, Barrett MS.
    Diagn Microbiol Infect Dis; 1998 Aug 17; 31(4):573-8. PubMed ID: 9764398
    [Abstract] [Full Text] [Related]

  • 28. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98.
    Critchley IA, Thornsberry C, Piazza G, Jones M, Hickey ML, Barth AL, Mendes C, Rossi FF, Sader HS, Teixeira LM, Sahm DF.
    Clin Microbiol Infect; 2000 Apr 17; 6(4):178-84. PubMed ID: 11168105
    [Abstract] [Full Text] [Related]

  • 29. Antimicrobial susceptibility of select respiratory tract pathogens in Dakar, Senegal.
    Ndiaye AG, Boye CS, Hounkponou E, Gueye FB, Badiane A.
    J Infect Dev Ctries; 2009 Oct 22; 3(9):660-6. PubMed ID: 19858566
    [Abstract] [Full Text] [Related]

  • 30. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ.
    Diagn Microbiol Infect Dis; 2008 Oct 22; 62(2):210-5. PubMed ID: 18715733
    [Abstract] [Full Text] [Related]

  • 31. Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.
    Karlowsky JA, Thornsberry C, Critchley IA, Jones ME, Evangelista AT, Noel GJ, Sahm DF.
    Antimicrob Agents Chemother; 2003 Jun 22; 47(6):1790-7. PubMed ID: 12760850
    [Abstract] [Full Text] [Related]

  • 32. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998.
    Zhanel GG, Karlowsky JA, Low DE, Hoban DJ.
    J Antimicrob Chemother; 2000 May 22; 45(5):655-62. PubMed ID: 10797089
    [Abstract] [Full Text] [Related]

  • 33. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H, Ito C, Yoshida T, Watanabe K, Mori T, Ohno I, Okada S, Igari J, Arakawa M, Igarashi K, Oguri T, Okada M, Ozaki K, Terai T, Aoki N, Inoue H, Nakadate T, Kitamura N, Sekine O, Suzuki Y, Ando M, Suga M, Sato K, Nakata K, Kusano N.
    Jpn J Antibiot; 1999 May 22; 52(5):353-97. PubMed ID: 10480048
    [Abstract] [Full Text] [Related]

  • 34. A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal.
    Melo-Cristino J, Fernandes ML, Serrano N, Portuguese Surveillance Group for the Study of Respiratory Pathogens.
    Microb Drug Resist; 2001 May 22; 7(1):33-8. PubMed ID: 11310801
    [Abstract] [Full Text] [Related]

  • 35. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I, Robbins M, Viljoen L, Brown DF.
    J Antimicrob Chemother; 2005 Feb 22; 55(2):200-8. PubMed ID: 15649996
    [Abstract] [Full Text] [Related]

  • 36. [Recent trends in incidence of respiratory tract pathogens and antimicrobial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis isolated in 1994 and 1995].
    Nishioka K, Ogihara H, Ohno I, Shirato K.
    Jpn J Antibiot; 1997 Sep 22; 50(9):768-75. PubMed ID: 9394237
    [Abstract] [Full Text] [Related]

  • 37. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N.
    Jpn J Antibiot; 1998 Jul 22; 51(7):437-74. PubMed ID: 9755430
    [Abstract] [Full Text] [Related]

  • 38. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F, Carnegy F, Willcock J, Amyes S.
    J Antimicrob Chemother; 2004 May 22; 53(5):793-6. PubMed ID: 15056640
    [Abstract] [Full Text] [Related]

  • 39. Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group.
    Fluit AC, Schmitz FJ, Jones ME, Acar J, Gupta R, Verhoef J.
    Int J Infect Dis; 1999 May 22; 3(3):153-6. PubMed ID: 10460927
    [Abstract] [Full Text] [Related]

  • 40. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.
    Doern GV.
    Otolaryngol Head Neck Surg; 2002 Dec 22; 127(6 Suppl):S17-23. PubMed ID: 12511856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.